---
layout: post
title: 'USAN Watch: September 2013'
date: '2013-11-10T16:13:00.002Z'
author: kott
tags:
- INNS and USANS
modified_time: '2013-11-10T16:23:19.668Z'
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-8994574428315883723
blogger_orig_url: http://chembl.blogspot.com/2013/11/missing-usans-for-september.html
---

<div class="post-header">
<div class="post-header-line-1">
</div>
</div>
<div class="post-body entry-content">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="https://lh3.ggpht.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for September, 2013 have recently been published. We actually missed September, due to switch over in service for the INNs, but now they're here.</span><br />
<br />
<table border="1">        <tbody>
<tr>
            <td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td>
            <td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td>
            <td><b>InChIKey (Parent)</b></td>
            <td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td>
            <td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td>
            <td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/aducanumab.pdf">aducanumab</a></td>
            <td>BIIB-037</td>
            <td>n/a</td>
            <td>monoclonal antibody</td>
            <td>therapeutic</td>
            <td>beta amyloid</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/aptorsen-sodium.pdf">aptorsen-sodium</a></td>
            <td>OGX-427</td>
            <td>n/a</td>
            <td>oligonucleotide</td>
            <td>therapeutic</td>
            <td>HSP27</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/asfotase-alfa.pdf">asfotase-alfa</a></td>
            <td>ALXN-1215, ENB-0040</td>
            <td>n/a</td>
            <td>enzyme</td>
            <td>therapeutic</td>
            <td>n/a</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/batefenterol.pdf">batefenterol</a>,&nbsp;<a href="http://www.ama-assn.org//resources/doc/usan/batefenterol-succinate.pdf">batefenterol-succinate</a></td>
            <td>GSK-961081A</td>
            <td>URWYQGVSPQJGGB-DHUJRADRSA-N</td>
            <td>synthetic small molecule</td>
            <td>therapeutic</td>
            <td>Muscarinic receptors, B2 receptor</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/bococizumab.pdf">bococizumab</a></td>
            <td>RN-316, PF-04950615</td>
            <td>n/a</td>
            <td>monoclonal antibody</td>
            <td>therapeutic</td>
            <td>PC9</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/dactolisib.pdf">dactolisib</a>,&nbsp;<a href="http://www.ama-assn.org//resources/doc/usan/dactolisib-tosylate.pdf">dactolisib-tosylate</a></td>
            <td>NVP-BEZ235-NX<br />
<div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<br /></div>
</div>
</div>
</td>
            <td>JOGKUKXHTYWRGZ-UHFFFAOYSA-N</td>
            <td>synthetic small molecule</td>
            <td>therapeutic</td>
            <td>MTOR, PI3K</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/deldeprevir.pdf">deldeprevir</a>,&nbsp;<a href="http://www.ama-assn.org//resources/doc/usan/deldeprevir-sodium.pdf">deldeprevir-sodium</a></td>
            <td>ACH-0142684, ACH-2684</td>
            <td>UDMJANYPQWEDFT-ZAWFUYGJSA-N</td>
            <td>synthetic small molecule</td>
            <td>therapeutic</td>
            <td>HCV NS3 PR</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/etiguanfacine.pdf">etiguanfacine</a></td>
            <td>SSP-1871</td>
            <td>NWKJFUNUXVXYGE-UHFFFAOYSA-N</td>
            <td>synthetic small molecule</td>
            <td>therapeutic</td>
            <td><br /></td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/faldaprevir.pdf">faldaprevir</a>,&nbsp;<a href="http://www.ama-assn.org//resources/doc/usan/faldaprevir-sodium.pdf">faldaprevir-sodium</a></td>
            <td>BI-201335</td>
            <td><br /></td>
            <td>synthetic small molecule</td>
            <td>therapeutic</td>
            <td>HCV NS3 PR</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/fedratinib.pdf">fedratinib</a></td>
            <td>SAR-302503; TG-101348</td>
            <td>JOOXLOJCABQBSG-UHFFFAOYSA-N</td>
            <td>synthetic small molecule</td>
            <td>therapeutic</td>
            <td>FLT3, JAK2</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/grazoprevir.pdf">grazoprevir</a></td>
            <td>n/a</td>
            <td>n/a</td>
            <td>synthetic small molecule</td>
            <td>therapeutic</td>
            <td><br /></td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/irinotecan-sucrosofate.pdf">irinotecan-sucrosofate</a></td>
            <td>MM-398, PEP-02</td>
            <td>n/a</td>
            <td>natural product derived small molecule</td>
            <td>therapeutic</td>
            <td>topo 1</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/luspatercept.pdf">luspatercept</a></td>
            <td>ACE-536</td>
            <td>n/a</td>
            <td>protein</td>
            <td>therapeutic</td>
            <td>TGF-B family</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/mavoglurant.pdf">mavoglurant</a></td>
            <td>AFQ-056</td>
            <td>ZFPZEYHRWGMJCV-ZHALLVOQSA-N</td>
            <td>synthetic small molecule</td>
            <td>therapeutic</td>
            <td>mGluR5</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/otlertuzumab.pdf">otlertuzumab</a></td>
            <td>TRU-016</td>
            <td>n/a</td>
            <td>monoclonal antibody</td>
            <td>therapeutic</td>
            <td>CD37</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/ralpancizumab.pdf">ralpancizumab</a></td>
            <td>RN317, PF-05335810</td>
            <td>n/a</td>
            <td>monoclonal antibody</td>
            <td>therapeutic</td>
            <td>PC9</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/romyelocel-l.pdf">romyelocel-l</a></td>
            <td>CLT-008</td>
            <td>n/a</td>
            <td>cellular therapy</td>
            <td>therapeutic</td>
            <td>n/a</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/roxadustat.pdf">roxadustat</a></td>
            <td>FG-4592; ASP-1517</td>
            <td>YOZBGTLTNGAVFU-UHFFFAOYSA-N</td>
            <td>synthetic small molecule</td>
            <td>therapeutic</td>
            <td>prolyl hydoxylase</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/simtuzumab.pdf">simtuzumab</a></td>
            <td>AB-0024; GS-6624</td>
            <td>n/a</td>
            <td>monoclonal antibody</td>
            <td>therapeutic</td>
            <td>LOXL2</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/sucroferric-oxyhydroxide.pdf">sucroferric-oxyhydroxide</a></td>
            <td>PA-21</td>
            <td>n/a</td>
            <td>inorganic</td>
            <td>sequestering agent</td>
            <td>n/a</td>
        </tr>
<tr>
            <td><a href="http://www.ama-assn.org//resources/doc/usan/tecemotide.pdf">tecemotide</a></td>
            <td>BLP-25</td>
            <td>n/a</td>
            <td>peptide vaccine</td>
            <td>peptide vaccine</td>
            <td>n/a</td>
        </tr>
</tbody>
    </table>
</div>
